Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agreement of renal function estimation equations for NOAC dosing
TCTR20220430001Not yet recruiting
- Sponsor
- Chulalongkorn University
- Start
- Jun 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial in thromboembolism, Atrial fibrillation (AFib) and venous thromboembolism (VTE), sponsored by Chulalongkorn University. Primary endpoint: Agreement between eGFR equations for NOAC dosing. Planned start Jun 2022; status: not yet recruiting.
02
Conditions
thromboembolismAtrial fibrillation (AFib)venous thromboembolism (VTE)
Beyond the preview
Go deeper on TCTR20220430001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220430001.